Dashboard
Manage Tickers

ALLO


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

allogene-therapeutics-announces-patient-screening-underway-for-pivotal-phase-2-alpha3-trial-at-rocky-mountain-cancer-centers-astera-cancer-care-and-norton-cancer-institute-alpha3-to-offer-car-t-as-first-line-treatment-at-community-cancer-centers-aiming-to-complete-enrollment-by-1h-2026-and-potential-bla-submission-in-2027
Allogene Therapeutics Announces Patient Sc...
07/01/2024 12:31:48

Patient Screening is Underway at Rocky Mountain Cancer Centers, Part of the US Oncology Network and Sarah Cannon Research Insti...

allogene-therapeutics-initiates-phase-2-trial-investigating-cemacabtagene-ansegedleucel-as-part-of-first-line-treatment-for-patients-with-large-b-cell-lymphoma-likely-to-relapse
Allogene Therapeutics Initiates Phase 2 Tr...
06/20/2024 12:38:44

ALPHA3 Trial Has the Potential to Position Cema-cel as Part of First Line (1L) Treatment for LBCL to Improve Cure Rates First P...

analyst-ratings-for-allogene-therapeutics
Analyst Ratings For Allogene Therapeutics
05/31/2024 12:00:17

piper-sandler-initiates-coverage-on-allogene-therapeutics-with-overweight-rating-announces-price-target-of-11
Piper Sandler Initiates Coverage On Alloge...
05/31/2024 09:53:54

Piper Sandler analyst Biren Amin initiates coverage on Allogene Therapeutics (NASDAQ:ALLO) with a Overweight rating and anno...

why-james-hardie-industries-shares-are-trading-lower-by-around-14-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why James Hardie Industries Shares Are Tra...
05/21/2024 17:36:28

why-larimar-therapeutics-shares-are-trading-higher-by-18-here-are-20-stocks-moving-premarket
Why Larimar Therapeutics Shares Are Tradin...
05/21/2024 12:12:19

oppenheimer-maintains-outperform-on-allogene-therapeutics-lowers-price-target-to-13
Oppenheimer Maintains Outperform on Alloge...
05/21/2024 12:00:55

Oppenheimer analyst Mark Breidenbach maintains Allogene Therapeutics (NASDAQ:ALLO) with a Outperform and lowers the price ta...

hc-wainwright--co-maintains-buy-on-allogene-therapeutics-lowers-price-target-to-9
HC Wainwright & Co. Maintains Buy on Allog...
05/16/2024 11:49:05

HC Wainwright & Co. analyst Robert Burns maintains Allogene Therapeutics (NASDAQ:ALLO) with a Buy and lowers the price t...

breaking-down-allogene-therapeutics-5-analysts-share-their-views
Breaking Down Allogene Therapeutics: 5 Ana...
05/15/2024 19:02:31

truist-securities-maintains-buy-on-allogene-therapeutics-maintains-17-price-target
Truist Securities Maintains Buy on Allogen...
05/15/2024 18:17:40

Truist Securities analyst Asthika Goonewardene maintains Allogene Therapeutics (NASDAQ:ALLO) with a Buy and maintains $17 pr...

why-arcutis-biotherapeutics-shares-are-trading-higher-by-29-here-are-20-stocks-moving-premarket
Why Arcutis Biotherapeutics Shares Are Tra...
05/15/2024 12:14:56

dlocal-allogene-therapeutics-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
DLocal, Allogene Therapeutics And Other Bi...
05/15/2024 10:12:21

allogene-therapeutics-files-for-offering-of-up-to-3793m-shares-of-common-stock
Allogene Therapeutics Files For Offering O...
05/14/2024 20:43:37

stifel-maintains-hold-on-allogene-therapeutics-raises-price-target-to-46
Stifel Maintains Hold on Allogene Therapeu...
05/14/2024 10:51:51

Stifel analyst Benjamin Burnett maintains Allogene Therapeutics (NASDAQ:ALLO) with a Hold and raises the price target from $...

allogene-therapeutics-prices-37931035-share-common-stock-offering-at-290share-gross-proceeds-110m
Allogene Therapeutics Prices 37,931,035 Sh...
05/13/2024 20:50:58

allogene-therapeutics-q1-2024-gaap-eps-038-beats-041-estimate-sales-22000k-down-from-30000k-yoy
Allogene Therapeutics Q1 2024 GAAP EPS $(0...
05/13/2024 20:06:36

Allogene Therapeutics (NASDAQ:ALLO) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of...

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
05/06/2024 12:06:38

allogene-therapeutics-awarded-15m-grant-from-california-institute-for-regenerative-medicine-to-advance-development-of-allogeneic-car-t-in-renal-cell-carcinoma
Allogene Therapeutics Awarded $15M Grant F...
04/26/2024 12:35:19

$15 million CIRM Grant Supports the Ongoing Phase 1 TRAVERSE Trial Evaluating ALLO-316 in Patients with Advanced or Metastatic ...

to-the-moon-a-look-inside-an-etf-focused-on-companies-at-the-cutting-edge-of-innovation
To The Moon! A Look Inside An ETF Focused ...
04/18/2024 18:29:09

hc-wainwright--co-reiterates-buy-on-allogene-therapeutics-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Allo...
03/19/2024 10:55:34

HC Wainwright & Co. analyst Robert Burns reiterates Allogene Therapeutics (NASDAQ:ALLO) with a Buy and maintains $10 pri...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)